Keyword Analysis & Research: scholar rock
Keyword Research: People who searched scholar rock also searched
Search Results related to scholar rock on Search Engine
-
Scholar Rock - Discovery and Development of Innovative Medicines
https://scholarrock.com/
WEBApr 12, 2024 · Scholar Rock works across therapeutic areas and shines new light on the overlooked to better target disease. We are on a mission to discover, develop, and deliver life-changing therapies. We promote a spirit of curiosity and collaboration with the goal of achieving the best results for patients.
DA: 5 PA: 32 MOZ Rank: 4
-
Our Pipeline - Scholar Rock
https://scholarrock.com/our-pipeline/
WEBThen, we use our scientific insights combined with our proprietary platform to highlight opportunities outside commonly-practiced approaches. Spinal Muscular Atrophy. Learn More About Our Work with SMA. Discovery / Preclinical. Phase 1. Phase 2. Phase 3. Apitegromab (selective anti-latent myostatin) Expand / Collapse.
DA: 69 PA: 2 MOZ Rank: 74
-
Learn About Our Values and Team - Scholar Rock
https://scholarrock.com/our-company/
WEBTo drive the best outcomes for patients and families, we at Scholar Rock: Focus on the Patient. We champion what matters to patients and their families. Cultivate Curiosity. Passion for science is our pathway to excellence, allowing thoughtful questions to drive daring ideas. Collaborate With Purpose.
DA: 20 PA: 21 MOZ Rank: 10
-
Scholar Rock Announces FDA Clearance of IND Application to …
https://finance.yahoo.com/news/scholar-rock-announces-fda-clearance-130000577.html
WEBJan 23, 2024 · Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity. Business Wire. Tue, Jan 23, 2024 8 min read.
DA: 78 PA: 43 MOZ Rank: 31
-
Our Science - Fighting Disease Using Technology - Scholar Rock
https://scholarrock.com/our-science/
WEBFeb 9, 2024 · Fighting disease through unexpected practice. By combining structural insights with our antibody drug discovery platform and deep understanding of the underlying biology, our scientific outlook is all-encompassing. We consider ideas, findings, and beliefs about validated targets (past and present) and extend them with our critical science to ...
DA: 45 PA: 32 MOZ Rank: 82
-
Scholar Rock Provides Corporate Update and Highlights …
https://www.businesswire.com/news/home/20240104939112/en/Scholar-Rock-Provides-Corporate-Update-and-Highlights-Priorities-for-2024
WEBJan 4, 2024 · Scholar Rock Provides Corporate Update and Highlights Priorities for 2024 | Business Wire. - Advancing industry-leading antimyostatin pipeline, comprised of multiple, novel assets with...
DA: 99 PA: 42 MOZ Rank: 21
-
Scholar Rock Presents New Data from Phase 1 DRAGON Trial …
https://www.businesswire.com/news/home/20231103455994/en/Scholar-Rock-Presents-New-Data-from-Phase-1-DRAGON-Trial-Showing-Promising-Anti-Tumor-Activity-in-Anti-PD-1-Resistant-Metastatic-ccRCC-Patients-and-Supporting-SRK-181-Continued-Tolerability
WEBNov 3, 2023 · Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability |...
DA: 88 PA: 37 MOZ Rank: 79
-
Scholar Rock Announces Completion of Enrollment for the Phase …
https://investors.scholarrock.com/news-releases/news-release-details/scholar-rock-announces-completion-enrollment-phase-3-sapphire
WEBSep 19, 2023 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Sep. 19, 2023-- Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced today that it has completed enrollment of the SAPPHIRE Phase 3 trial …
DA: 86 PA: 97 MOZ Rank: 73
-
Learn About Our Unique Platform Here at Scholar Rock
https://scholarrock.com/our-science/platform/
WEBScholar Rock. Careers. Contact Us. Our Company. Management Team. Board of Directors. Partnering. Learn About Our Company. Our Science. Structural Insights & the Growth Factor Precursor. Platform. Publications & Posters. Learn About Our Science. Our Pipeline. Spinal Muscular Atrophy. Oncology. Anemia. Fibrosis. Clinical Trials.
DA: 15 PA: 61 MOZ Rank: 30
-
Scholar Rock Announces Completion of Enrollment for the Phase …
https://finance.yahoo.com/news/scholar-rock-announces-completion-enrollment-120000711.html
WEBCAMBRIDGE, Mass., September 19, 2023--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth...
DA: 58 PA: 72 MOZ Rank: 57
